-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Spyre Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q1 2024.
- Spyre Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -39.4K %, a 480% decline year-over-year.
- Spyre Therapeutics, Inc. annual Operating Margin for 2023 was -27.3K %, a 651% decline from 2022.
- Spyre Therapeutics, Inc. annual Operating Margin for 2022 was -3.64K %, a 939% decline from 2021.
- Spyre Therapeutics, Inc. annual Operating Margin for 2021 was -350 %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)